Faculty profile
Karina Lebel
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université du Québec à Montréal directory, so their courses and email address may be missing. Find their university profile.
Latest papers
Parkinson's disease patients experiencing peak-dose dyskinesia redistribute involuntary movements throughout their body to improve motor control.
Parkinsonism & related disorders · 2019 · first author
Latest funding
- $707,626
The impact of levodopa-induced dyskinesia on the physical and social participation of patients with advanced Parkinson's disease and their spousal caregiver: a digital phenotyping study.
CIHR · 2023 · Principal investigator
- $100,000
The impact of levodopa-induced dyskinesia on the physical and social participation of patients with advanced Parkinson's disease and their spousal caregiver: a digital phenotyping study.
CIHR · 2022 · Principal investigator
1 publications.
Parkinson's disease patients experiencing peak-dose dyskinesia redistribute involuntary movements throughout their body to improve motor control.
Lebel K, Duval C, Goubault E, Bogard S, Blanchet PJ
The impact of levodopa-induced dyskinesia on the physical and social participation of patients with advanced Parkinson's disease and their spousal caregiver: a digital phenotyping study.
Principal investigators: Duval, Christian; Beaudet, Line; Blanchet, Pierre J; Boissy, Patrick; Daneault, Jean-François; Huot, Philippe; Lambert, Sylvie; Lebel, Karina
Keywords: Dyad; Dyskinesia; Levodopa; Mobility; Motor Complications; Parkinson'S Disease; Sensors
The impact of levodopa-induced dyskinesia on the physical and social participation of patients with advanced Parkinson's disease and their spousal caregiver: a digital phenotyping study.
Principal investigators: Duval, Christian; Beaudet, Line; Blanchet, Pierre J; Boissy, Patrick; Daneault, Jean-François; Huot, Philippe; Lambert, Sylvie; Lebel, Karina
Keywords: Burden; Dyad; Dyskinesia; Levodopa; Mobility; Motor Complications; Mutuality; Parkinson'S Disease; Quality Of Life; Sensors
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.